ESH 2017 | Novel targets for AML

Name: Novel targets for AML
Uploaded: 2017-10-05T00:00:00.000Z
Duration: 1 min 21 s
Description: There are currently a number of ongoing clinical trials for acute myeloid leukemia (AML) that are targeting nuclear exporters. In this video, recorded at the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH), Ramiro Garzon, MD, from Ohio State University, Columbus, OH, discusses the promise of these novel agents.

Ramiro Garzon • 5 Oct 2017

ESH 2017

Acute Myeloid Leukemia

There are currently a number of ongoing clinical trials for acute myeloid leukemia (AML) that are targeting nuclear exporters. In this video, recorded at the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH), Ramiro Garzon, MD, from Ohio State University, Columbus, OH, discusses the promise of these novel agents.